Get the Stockscreener App
0.0127
10.43%
0.0012
T 2 Biosystems Inc stock is traded at $0.0127, with a volume of 5,650.
It is up +10.43% in the last 24 hours and up +15.45% over the past month.
See More
Previous Close:
$0.0115
Open:
$0.011
24h Volume:
5,650
Relative Volume:
0.56
Market Cap:
$N/A
Revenue:
$7.68M
Net Income/Loss:
$-42.95M
P/E Ratio:
-0.000556
EPS:
-22.8421
Net Cash Flow:
$-36.62M
1W Performance:
+15.45%
1M Performance:
+15.45%
6M Performance:
-90.24%
1Y Performance:
-95.82%
1-Day Range:
$0.011
$0.015
1-Week Range:
$0.011
$0.015
52-Week Range:
$0.005
$0.165
T 2 Biosystems Inc Stock (TTOO) Company Profile
Name
T 2 Biosystems Inc
Sector
Industry
Phone
-
Address
-
Compare TTOO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TTOO
T 2 Biosystems Inc
|
0.0127 | 0 | 7.68M | -42.95M | -36.62M | -22.84 |
|
TMO
Thermo Fisher Scientific Inc
|
570.16 | 216.37B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
224.70 | 161.42B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
693.18 | 55.94B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
139.19 | 39.80B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
221.68 | 38.08B | 15.90B | 1.28B | 2.21B | 7.2842 |
T 2 Biosystems Inc Stock (TTOO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-27-21 | Downgrade | Alliance Global Partners | Buy → Neutral |
| Oct-08-20 | Initiated | BTIG Research | Buy |
| Nov-26-19 | Downgrade | Janney | Buy → Neutral |
| Aug-01-19 | Downgrade | Alliance Global Partners | Buy → Neutral |
| Jul-31-19 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jul-31-19 | Downgrade | Janney | Buy → Neutral |
| May-16-19 | Initiated | Alliance Global Partners | Buy |
| Mar-08-19 | Reiterated | H.C. Wainwright | Buy |
| Jun-01-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| May-30-18 | Reiterated | H.C. Wainwright | Buy |
| May-29-18 | Reiterated | WBB Securities | Strong Buy |
| Mar-29-18 | Reiterated | H.C. Wainwright | Buy |
| Jan-29-18 | Initiated | Goldman | Neutral |
| Oct-18-17 | Initiated | H.C. Wainwright | Buy |
| Mar-15-17 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Nov-10-16 | Resumed | Leerink Partners | Mkt Perform |
| Nov-02-16 | Reiterated | Cantor Fitzgerald | Buy |
| Jul-20-16 | Upgrade | WBB Securities | Buy → Strong Buy |
| Jun-22-16 | Upgrade | WBB Securities | Speculative Buy → Buy |
| Apr-12-16 | Reiterated | Canaccord Genuity | Buy |
| Feb-17-16 | Initiated | WBB Securities | Speculative Buy |
View All
T 2 Biosystems Inc Stock (TTOO) Latest News
T2 Biosystems (NASDAQ:TTOO) Shares Cross Above 50-Day Moving Average – What’s Next? - Defense World
Stocks in play: Microbix Biosystems Inc. - The Globe and Mail
T2 Biosystems Inc. (TTOO) Stock Price | Live Quotes & Charts | OTO - StocksToTrade
T2 Biosystems (NASDAQ:TTOO) Shares Cross Above 50 Day Moving Average – What’s Next? - Defense World
Tangible book value per share of T2 Biosystems, Inc. – LSE:0A57 - TradingView
Ocean Dx sepsis test matches gold standard in early study - BioWorld MedTech
TTOO Interactive Stock Chart | T2 Biosystems, Inc. Stock - Yahoo Finance
T2 Biosystems Inc. (TTOO): 2025 Product Pipeline and Strategy Analysis Report - Yahoo Finance
Why retail investors favor Rapid Micro Biosystems Inc. stock2025 Trading Volume Trends & Low Risk Entry Point Tips - nchmf.gov.vn
Rapid Micro Biosystems And 2 Promising Penny Stocks To Watch - Yahoo Finance
GBS (NYSE:GBS) versus T2 Biosystems (NASDAQ:TTOO) Head-To-Head Survey - Defense World
Contestants Turn in a Terrific Short Selling Performance - TradingView
Reviewing T2 Biosystems (NASDAQ:TTOO) & Titan Medical (NASDAQ:TMDIF) - Defense World
Revenue per share of T2 Biosystems, Inc. – OTC:TTOO - TradingView
EBIT per share of T2 Biosystems, Inc. – OTC:TTOO - TradingView
T2 Biosystems (NASDAQ:TTOO) Stock Crosses Below Two Hundred Day Moving Average – Here’s Why - Defense World
Phase 2 HER2 Clinical Trial Manufacturing Commenced, WSU Imaging Optimisation Program Underway - Investing News Network
Lyme Disease Pipeline 2025: In-Depth Clinical Trials Analysis And Emerging Therapies Report By Delveinsight Abbott, Bio-Rad Laboratories, Inc., Covance Inc.F. Hoffmann-La Roche AG, T2 Biosystems - Menafn.com
Reviewing Titan Medical (NASDAQ:TMDIF) and T2 Biosystems (NASDAQ:TTOO) - Defense World
Sepsis Diagnostics Market Poised for Remarkable Expansion by 2035, Reveals Prophecy Market Insights Study - newstrail.com
Will Retractable Technologies Inc. outperform the marketJuly 2025 Outlook & High Accuracy Trade Alerts - Newser
T2 Biosystems, Inc. (NASDAQ:TTOO) Sees Significant Drop in Short Interest - Defense World
Rapid Micro Biosystems, Inc. (RPID) Reports Q2 Loss, Misses Revenue Estimates - MSN
Rapid Micro Biosystems Reports 15% Recurring Revenue Growth, Lands Major $45M Financing Deal - Stock Titan
Apyx Medical Strengthens Global Sales Leadership with Strategic Hires as New AYON System Launches - Stock Titan
Short Interest in T2 Biosystems, Inc. (NASDAQ:TTOO) Expands By 1,146.7% - Defense World
Targeting iron regulatory protein 2 (IRP2) to disrupt iron metabolism enhances radiosensitivity through mitochondrial dysfunction in breast cancer cells - Nature
Rapid Micro: Lake Street initiates coverage with Buy rating, PT $8. - AInvest
T2 Biosystems (NASDAQ:TTOO) versus InspireMD (NYSE:NSPR) Financial Review - Defense World
What analysts say about Rapid Micro Biosystems Inc. stockUnmatched profit potential - Autocar Professional
Head to Head Survey: Presbia (OTCMKTS:LENSF) & T2 Biosystems (NASDAQ:TTOO) - Defense World
Does Rapid Micro Biosystems Inc. stock pay reliable dividends200 Percent Profit Outlook - beatles.ru
Vivid Dx Appoints Diagnostics Veteran John Sperzel as Chief Executive Officer and Board Member - GlobeNewswire Inc.
TTOO SEC FilingsT2 Biosystems 10-K, 10-Q, 8-K Forms - Stock Titan
Upcoming Earnings Reports and Analyst Ratings Actions - AInvest
Delisting of Securities from The Nasdaq Stock Market - Yahoo Finance
Emerging Lyme Disease Diagnostics Market Opportunities - openPR.com
North American Morning Briefing: Stock Futures Down, Earnings Expectations, and Analyst Ratings Actions - AInvest
Critical Comparison: T2 Biosystems (NASDAQ:TTOO) vs. ClearPoint Neuro (NASDAQ:CLPT) - Defense World
Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
T2 BIOSYSTEMS Earnings Preview: Recent $TTOO Insider Trading, Hedge Fund Activity, and More - Nasdaq
Biotech layoff tracker: 21 companies cut 1,000 jobs in Q1 2025 - The Business Journals
Rapid Micro Biosystems And 2 Other Promising Penny Stocks To Consider - simplywall.st
Microbix Biosystems Leads These 3 TSX Penny Stocks To Watch - simplywall.st
Rapid Micro Biosystems, Inc. (RPID): Among the Hot Penny Stocks to Buy Now - Yahoo Finance
T2 Biosystems initiates major layoffs, seeks asset sale - Investing.com
Medical diagnostics firm T2 Biosystems cuts ‘substantially all’ workers - The Business Journals
T2 Biosystems Reduces Workforce Amid Nasdaq Delisting Notice - TipRanks
T2 Biosystems, Inc. Balance Sheet – OTC:TTOO - TradingView
TTOO Stock Price and Chart — OTC:TTOO - TradingView
Epicore Biosystems scores $26M to expand sweat-sensing wearable technology - Mobi Health News
T 2 Biosystems Inc Stock (TTOO) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.49%
Cap:
|
Volume (24h):